Wanjun Yu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 15
- RNA modifications and cancer 4
-
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 12
- Co-authors
- Jipeng Li (14 shared papers)Yiping Wang (6 shared papers)Yulan Song (2 shared papers)Jun Chen (1 shared paper)Huaying Wang (14 shared papers)Jian‐Ping Luo (2 shared papers)Yi‐Ping Wang (1 shared paper)Fun Sun Chu (5 shared papers)
- Journals
- Journal of Cellular Physiology (2 papers)Hereditas (2 papers)Food Bioscience (2 papers)Tumor Biology (2 papers)International Immunopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Wanjun Yu
62 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 839
- Molecular Biology 979
- Emergency Medical Services 59
- Pulmonary and Respiratory Medicine 227
- Immunology 134
Countries citing papers authored by Wanjun Yu
This map shows the geographic impact of Wanjun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanjun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanjun Yu more than expected).
Fields of papers citing papers by Wanjun Yu
This network shows the impact of papers produced by Wanjun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanjun Yu. The network helps show where Wanjun Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanjun Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 189 | |
| 2 | 2012 | 119 | |
| 3 | 2014 | 117 | |
| 4 | LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204. | 2016 | 104 |
| 5 | 2013 | 84 | |
| 6 | 2014 | 73 | |
| 7 | 2018 | 64 | |
| 8 | 2012 | 59 | |
| 9 | 2021 | 52 | |
| 10 | 2016 | 45 | |
| 11 | 2019 | 42 | |
| 12 | 2017 | 39 | |
| 13 | 2018 | 34 | |
| 14 | 1999 | 33 | |
| 15 | 2019 | 33 | |
| 16 | 2022 | 30 | |
| 17 | A comparison of ultrasound and magnetic resonance imaging to assess visceral fat in the metabolic syndrome. | 2007 | 28 |
| 18 | 2015 | 27 | |
| 19 | 2015 | 23 | |
| 20 | 1998 | 20 |
About Wanjun Yu
Wanjun Yu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 68 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (15 papers), Cancer-related molecular mechanisms research (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Lung Cancer Research Studies (5 papers), Pediatric health and respiratory diseases (4 papers), RNA modifications and cancer (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (839 citations), Molecular Biology (979 citations), Emergency Medical Services (59 citations), Pulmonary and Respiratory Medicine (227 citations) and Immunology (134 citations). Wanjun Yu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jipeng Li, Yiping Wang, Yulan Song, Jun Chen, Huaying Wang, Jian‐Ping Luo, Yi‐Ping Wang, Fun Sun Chu, Mingwei Jin and Shanfeng Li. Their work appears in journals such as Journal of Cellular Physiology, Hereditas, Food Bioscience, Tumor Biology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.